I am very interested in EIQ, however, it looks like ultromics ( developed with oxford uni) has first in class advantage. Already has FDA approval. I am aware ultromics is initially interested mainly in heart failure, but only a matter of time to move onto AS. Does EIQ have any sig advantage over Ultromics?
I am very interested in EIQ, however, it looks like ultromics (...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $83.33M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.5¢ | 15.0¢ | $103.8K | 685.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99996 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 26266 | 2 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| EIQ (ASX) Chart |